Merck & Co., Inc. (NYSE:MRK) closed its last session at $55.87. The stock traded within a range of $55.22 and $55.97. The company operates in the Healthcare sector with a market capitalization of 152.63 Million. Trading volume for Merck & Co., Inc. was 12.08 Million in its previous trading session. Currently, Merck & Co., Inc. (NYSE:MRK) has an average volume of 10.58 Million.
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. Merck also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
Merck & Co., Inc. (NYSE:MRK) received a Buy rating from 3 analysts. 1 analysts gave its stock an Outperform rating. 1 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.
Merck & Co., Inc. (NYSE:MRK) touched its 1-Year High price of $66.80 on 03/01/17 and its 1-Year Low price of $53.63 on 11/20/17.
EPS & Financials
Merck & Co., Inc. (NYSE:MRK) reported its EPS in the last quarter as $1.11/Share beating the analyst estimate of $1.03/Share by a difference of $0.08. This showed a surprise of 7.8% in the last quarter earnings.
For the current quarter, 17 analysts are projecting a mean EPS of $0.94/share. According to their observations and findings, the stock could provide a high EPS of $0.95/share and a low EPS of $0.9/share.
Analysts believe that the company has the potential to earn average revenue of $10.49 Billion for the current quarter. According to their predictions high & low revenue estimates are 10.61 Billion and 10.39 Billion respectively.
By taking a look at the stock’s current statistics it can gauged that the stock candle is BULLISH with MEDIUM volatility. Merck & Co., Inc. (NYSE:MRK) has a 20-Day average volume of 12.11 Million. According to today’s trading volume Merck & Co., Inc. is BELOW its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.
Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BEARISH signal. The 100-Day trend also shows a BEARISH trend as well.
The company currently has an insider ownership of 0.05 Percent and Institutional ownership of 76.3 Percent. The return on assets stands at 3%, Return on Equity currently is 7.2% and the Return on Investment value is 6.4%.
Merck & Co., Inc. (NYSE:MRK) gross margin percentage stands at 76.4% while its operating margin for the past trailing twelve month is 8.3 percent and its overall profit margin (ttm) is 7.2 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 1.25% with a 50-Day Simple Moving Average of -6.62 percent. As of today, the company has a SMA200 (200-day simple moving average) of -11.11 Percent. The Stock has YTD (year to date) performance of -5.1 percent.
The TTM operating margin for the company stands at 8.3%. The return on invested capital is at 6.4%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 0.
The company’s stock is currently moving with a -ve distance from the 200 day SMA of approximately -11.11%, and has a solid year to date (YTD) performance of -5.1% which means that the stock is constantly adding to its value from the previous fiscal year end price.